Quest diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the united states

New capabilities include personalized patient access to quest's national network of 2,100 patient service centers and 5 ,000 mobile and at-home phlebotomists, to support patient-compliant pre- and post-transplant testing and nationwide access, regardless of surgical center location secaucus, n.j. , march 22, 2023 /prnewswire/ -- quest diagnostics (nyse: dgx), the nation's leading provider of diagnostic information services, today unveiled a comprehensive suite of advanced diagnostics and support services designed to broaden access to laboratory tests for transplanting solid organ, human cells and tissue.
DGX Ratings Summary
DGX Quant Ranking